{
  "pmcid": "12347489",
  "sha256": "df095d69b90fa5ac67ca6f749bb5eb6eb27f1471165c8e5b453b5d6a709195c7",
  "timestamp_utc": "2025-11-09T23:33:59.166940+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.1291882780083,
    "reading_ease": 20.59137577800834,
    "word_count": 241
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of the Dor Procedure with Intraoperative Substrate Mapping for Refractory Ventricular Tachycardia"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomised to receive either the Dor procedure with intraoperative substrate mapping and ablation or standard care."
      },
      "Participants": {
        "score": 2,
        "evidence": "Conducted at a tertiary care center, this randomised controlled trial included patients with drug-resistant recurrent VT and LV aneurysms."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised to receive either the Dor procedure with intraoperative substrate mapping and ablation or standard care."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was VT recurrence, evaluated over a 28-month follow-up period."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was achieved using a computer-generated sequence, with allocation concealment via sealed envelopes."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Due to the nature of the intervention, blinding was not feasible."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Two participants were randomised, with one in each group."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Both participants were analysed per protocol."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The intervention group demonstrated no VT recurrence at 28 months, while the control group experienced VT recurrence."
      },
      "Harms": {
        "score": 1,
        "evidence": "with no major complications reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not reported."
      }
    },
    "total_score": 15,
    "max_score": 25
  }
}